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Cigarette smoke is a complex chemical mixture that causes a variety of diseases, such as lung
cancer. With the electrically heated cigarette smoking system (EHCSS), temperatures are ap-
plied to the tobacco below those found in conventional cigarettes, resulting in less combustion,
reduced yields of some smoke constituents, and decreased activity in some standard toxicologi-
cal tests. The ﬁrst generation of electrically heated cigarettes (EHC) also resulted in increased
formaldehyde yields; therefore, a second generation of EHC was developed with ammonium
magnesium phosphate (AMP) in the cigarette paper in part to address this increase. The toxico-
logical activity of mainstream smoke from these two generations of EHC and of a conventional
reference cigarette was investigated in two studies in rats: a standard 90-day inhalation toxicity
study and a 35-day inhalation study focusing on lung inﬂammation. Many of the typical smoke
exposure-related changes were found to be less pronounced after exposure to smoke from the
second-generation EHC with AMP than to smoke from the ﬁrst-generation EHC or the conven-
tional reference cigarette, when compared on a particulate matter or nicotine basis. Differences
betweentheEHCwithoutAMPandtheconventionalreferencecigarettewerenotasprominent.
Overall, AMP incorporated in the EHC cigarette paper reduced the inhalation toxicity of the
EHCSS more than expected based on the observed reduction in aldehyde yields.
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Cigarettesmokeisacomplexmixturethatcausesavarietyof
diseases,suchaslungcancer,chronicobstructivepulmonarydis-
ease (COPD), and cardiovascular disease (U.S. Department of
HealthandHumanServices,2004;InternationalAgencyforRe-
searchonCancer,2004).Ithasbeenhypothesizedthatthechem-
ical composition of mainstream smoke (MS) and consequently
its toxicological effects depend to a great extent on the burning
temperatureofthetobacco(Patskan&Reininghaus,2003).Sup-
portiveevidencestemsfrompyrolysisexperimentswithtobacco
showing a decreased yield of many toxic MS constituents with
decreasing temperature (Torikai et al., 2004). The mutagenic-
ity of cigarette smoke condensate was also found to be reduced
when tobacco was pyrolyzed at temperatures below those found
in conventional cigarettes (White et al., 2001). One approach
using the association between lower temperature and reduced
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toxicological effects is the electrically heated cigarette smoking
system (EHCSS), which comprises an electronically controlled
heating device in a specially designed lighter as well as spe-
cially designed cigarettes. These electrically heated cigarettes
(EHC) are inserted into the smoking device, which allows pre-
cise regulation of the time course and amount of energy sup-
plied to the tobacco during each puff by means of heater blades
(Patskan & Reininghaus, 2003). This controlled heating of the
tobacco results in a distinctly lower temperature applied to the
tobacco than that found in the burning cone of conventional
cigarettes. Because of its design, the EHCSS produces practi-
cally no sidestream smoke between puffs, and because of the
lowertemperature,thecompositionofMSfromtheEHCSSdif-
fers considerably from that of conventional cigarettes (Stabbert
et al., 2003).
With the ﬁrst-generation EHCSS, in vitro experiments
showedlowertoxicologicalresponsescomparedtoconventional
reference cigarettes for cytotoxicity in the neutral red assay and
genotoxicityoftotalparticulatematter(TPM)intheSalmonella
reverse mutation assay and the mouse lymphoma thymidine ki-
naseassay(Tewesetal.,2003;Roemeretal.,2004;Schramkeet
al., 2006). In vivo results from a 90-day inhalation study in rats
were not quite as conclusive as in vitro results (Terpstra et al.,
2003):WhentheeffectsofMSfromtheEHCSSwerecompared
to those of a conventional reference cigarette, the University of
Kentucky Reference Cigarette 1R4F (Diana & Vaught, 1990),
results indicated the overall toxicity of diluted MS from the
EHCSS to be lower than that of the 1R4F when calculated on a
per cigarette basis, but not when calculated on the basis of equal
TPM concentration in the exposure chambers (Terpstra et al.,
2003). This can be attributed mainly to the lower TPM yield per
cigarette for the EHCSS compared to the 1R4F.
Apart from signiﬁcant reductions in the yields of almost
all analyzed toxicologically relevant constituents in the MS of
the ﬁrst-generation EHCSS compared to that from the con-
ventional reference cigarette, the formaldehyde concentration
per milligram TPM was approximately sevenfold higher (Stab-
bert et al., 2003). Because formaldehyde is a low-temperature
degradation product, this increase was attributed to the reduc-
tion in maximum temperature from ∼950◦C for a conventional
cigarette to ∼600◦C for the EHCSS (Patskan & Reininghaus,
2003). One approach used to mitigate this was to attempt to in-
ﬂuence the trapping of formaldehyde by other MS constituents.
For the second-generation EHCSS, this concept was realized by
replacingCaCO3 inthecigarettepaperwithammoniummagne-
sium phosphate (AMP) (Fournier & Paine, 2001). The intention
wast odecrease formaldehyde by chemical reaction with am-
monia released from AMP, bearing in mind that this might yield
condensation products, such as hexamethylenetetramine (HMT,
also called urotropin). The impact of AMP incorporation on the
chemicalcompositionofMSandwithinvitrotestsystemsisre-
ported and discussed in detail in a parallel publication (Roemer
et al., 2008). Brieﬂy, AMP incorporation resulted in decreased
concentrations of a variety of toxic MS constituents, including
formaldehyde,withdecreasedcytotoxicityintheneutralredup-
take assay and decreased TPM mutagenicity in the Salmonella
reverse mutation assay. To complement the valuable informa-
tion on toxicity obtained from the chemical analysis and these
in vitro tests, in vivo tests were performed. The objective of the
current study was to investigate the toxicological activity in rats
of MS from two generations of EHC (with and without AMP in
the cigarette paper) and a conventional reference cigarette, the
1R4F. Two studies were conducted: a standard 90-day inhala-
tion toxicity study with endpoints chosen according to OECD
guideline 413, and a 35-day inhalation study focusing on lung
inﬂammation. This extension of the standard inhalation toxic-
ity assay with a pulmonary inﬂammation assay was designed to
address the growing interest in the role of altered inﬂammatory
processesinsmoke-relateddiseases(U.S.DepartmentofHealth
and Human Services, 2004).
MATERIALS AND METHODS
Experimental Design
Two subchronic cigarette smoke inhalation studies in rats
wereconducted:a90-dayinhalationtoxicitystudyanda35-day
pulmonary inﬂammation study.
90-Day Inhalation Toxicity Study. Guideline 413 from
the Organization for Economic Cooperation and Development
(OECD) guidelines for the testing of chemicals (Organiza-
tion for Economic Cooperation and Development, 1981) has
been adapted for the evaluation of cigarette modiﬁcations (e.g.,
Ayres et al., 2001; Vanscheeuwijck et al., 2002; Terpstra et
al., 2003; Higuchi et al., 2004; Carmines & Gaworski, 2005).
The inhalation toxicity of MS from a ﬁrst-generation EHC
(EHC-CaCO3) and a second-generation EHC with AMP in
the cigarette paper (EHC-AMP) was compared to that of a
conventional reference cigarette, the University of Kentucky
Reference Cigarette 1R4F. MS from the 1R4F was diluted to
three TPM target concentrations, i.e., 80 µg/L (low), 120 µg/L
(medium), and 160 µg/L (high), to allow for the establishment
of a concentration-response curve. This concentration-response
curve was used for the evaluation of the effects of EHCSS MS
(target concentration: 90 µg TPM/L). The MS exposure con-
centration for the two EHCs was chosen based on the inhalation
toxicity determined with the ﬁrst-generation EHCSS (Terpstra
et al., 2003) so that most of the anticipated biological effects
would be in the same range as those of the 1R4F. Each exposure
group was made up of 10 male rats and 10 female rats; control
groups were exposed to ﬁltered, conditioned fresh air (sham).
The reversibility and/or progression of MS-related effects were
investigated at the end of a 42-day postexposure period. For this
purpose, satellite groups of 10 male and 10 female rats each for
sham, the EHC-CaCO3, the EHC-AMP, and the highest dose
level of the 1R4F were kept without treatment for an additional
42 days after the end of the exposure period.
35-Day Pulmonary Inﬂammation Study. Pulmonary in-
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lung cells in bronchoalveolar lavage ﬂuid (BALF). Inﬂamma-
tion response induced by MS from the EHC-AMP (750 µg
TPM/L) was compared to that of the 1R4F, which was diluted
to 450 µg TPM/L and 600 µg TPM/L to allow determination of
a concentration-response curve. The 35-day inhalation period is
sufﬁcient for detecting changes in the distribution of free lung
cells in bronchoalveolar lavage ﬂuid (Friedrichs et al., 2006).
Each exposure group (including sham) was made up of 12 fe-
male rats. No signiﬁcant differences in response for female and
male rats have been reported.
Animals
Five-week-old outbred Sprague Dawley rats (Crl:CDBR),
bred under speciﬁc-pathogen-free conditions, were obtained
from Charles River Germany. The rats were barrier-maintained
inananimallaboratoryunitwithcontrolledhygienicconditions.
The laboratory air (ﬁltered fresh air) was conditioned, and posi-
tive pressure was maintained in the animal area. For the 90-day
inhalation toxicity study, room temperature was maintained at
21 ± 1◦C and relative humidity at 55 ± 5%. The light/dark
cycle was 12 h/12 h. Environmental conditions in the inﬂam-
mation study were similar and also in the comfort zone for the
rats.Goodhygienicconditionsweremaintainedasevidencedby
the low number of colony-forming units on the microbiological
media used for screening of the diet and drinking water, as well
as of the laboratory air and surfaces. Prestudy pathological and
histopathological examination of the respiratory tract, as well
as serological screening (Terpstra et al., 2003), revealed that the
rats were suitable for use in inhalation studies.
Identiﬁcation, housing, feeding, and watering were per-
formed as previously described (Vanscheeuwijck et al., 2002).
Chemical analytical screening revealed the diet to be in confor-
mity with NTP speciﬁcations (National Toxicology Program,
1992). After an acclimatization period of 7 days, rats were allo-
cated systematically to the exposure groups to achieve the same
body weight in all groups.
Cigarette Smoke Exposure
Cigarettes. The Reference Cigarette 1R4F was obtained
from the Tobacco and Health Institute at the University of Ken-
tucky (Diana & Vaught, 1990). In the absence of an existing
cigarette that closely matches the EHCSS, the 1R4F was se-
lected because it is a low “tar” American-blend cigarette, which
is representative of the current sales-weighted U.S. cigarette
market (Roemer et al., 2004). In addition, it is readily avail-
able to the general scientiﬁc community and can therefore serve
as a reference cigarette in the product testing of novel cigarettes
(Coggins et al., 1989). The ﬁrst-generation EHCSS is described
in detail elsewhere (Patskan & Reininghaus, 2003) and on the
Internet at www.pmusa-science.com. Brieﬂy, the EHCSS con-
sists of two parts, an electronically controlled smoking device
(lighter/heater) and specially designed cigarettes (EHCs). Apart
from some changes in the heater design, the main difference
between the ﬁrst- and second-generation EHCSS is a change in
the composition of the cigarette paper: The second generation
has AMP incorporated in the cigarette paper. Due to ongoing
technical development, there are also some minor differences
in the physical design and temperature program of the heater
device used in the inﬂammation study compared to that used in
the toxicity study. These minor differences are not considered
to affect the outcome of the study.
Smoke Generation. The cigarettes were conditioned ac-
cording to ISO standard 3402 (International Organization for
Standardization, 1991a) and smoked in basic conformity with
ISOstandards3308(InternationalOrganizationforStandardiza-
tion, 1991b) and 4387 (International Organization for Standard-
ization, 1991c). Some minor deviations from the ISO standards
were necessary for technical reasons (Stabbert et al., 2003).
MS from the 1R4F was generated on 30-port smoking ma-
chines(typeSM85,PhilipMorrisResearchLaboratoriesGmbH,
Germany; Reininghaus & Hackenberg, 1977), each equipped
with a 4-piston pump (Baumgartner and Coggins, 1980). The
MS was diluted with ﬁltered, conditioned fresh air to produce
the desired 1R4F concentrations and conveyed via glass tubing
to the exposure chamber. In both studies, the puff count ranged
from 8.2 ± 0.5 to 8.9 ± 0.5 puffs/cigarette and the cigarettes
were smoked to an average butt length of 34.3 ± 1.4 to 35.1 ±
1.2mm.Puffvolumeswere35.0mlonaveragewithamaximum
SD of 0.4 ml.
MS from the EHCSS was generated as previously described
(Stabbert et al., 2003). Brieﬂy, modiﬁed 30-port PMRL smok-
ing machines (type H2000 and H-IFL, Philip Morris Research
Laboratories GmbH, Germany) each equipped with a 4-piston
pump and 30 electric heaters (Figure 1) were used for smoke
generation. The total average heating energy per puff was ap-
proximately 24 J, applied during a 2-s puff (Patskan & Reining-
haus, 2003). The puff count for the EHCSS is ﬁxed to 8 puffs by
design. Puff volumes were 35.1 ml on average with a maximum
SD of 0.4 ml.
Exposure. For the 90-day inhalation toxicity study, the
ﬂow rate through the exposure chambers was between 92 and
96L/min,andthemeanageofthedilutedMSwas11s.Themean
temperature of the test atmospheres in the exposure chambers
was 23 ± 2◦C. The relative humidity of the ﬁltered, conditioned
fresh air used for dilution and sham exposure was 60 ± 6%. En-
vironmental conditions in the inﬂammation study were similar
and also in the comfort zone for the rats.
Theexposureregimenintheinhalationtoxicitystudywas6h
perday,7daysperweekfor90dayswitha42-daypostexposure
period. The exposure regimen in the inﬂammation study was
2×1hper day (with a 30-min break between the 2 hours), 7
days per week for 35 days with no postexposure period.
To monitor the stability and reproducibility of the smoke
generation, TPM, CO, nicotine, aldehydes, and particle size
distribution in the exposure chambers (at the breathing zone
of the rats, Figure 1) were determined according to pre-
viously described analytical methods (Haussmann et al.,
1998a).650 O. MOENNIKES ET AL.
FIG. 1. Mainstream smoke generation and exposure for the EHC. Smoking machine, tubing and exposure chamber.
Biological Endpoints
All rats were checked daily for mortality, moribundity, signs
oftoxicity,andinjury.Threesystematicallyselectedratspersex
and group were examined speciﬁcally for general condition and
behavior shortly after each daily exposure. Body weight (indi-
vidual) and food consumption (group-wise, inhalation toxicity
study) were determined at least once per week.
Respiratory parameters measured by head-out single-
chamberplethysmography,steady-stateproportionofbloodcar-
boxyhemoglobin (COHb) (Klimisch et al., 1974; Tyuma et al.,
1981), and representative nicotine metabolites in 24-h urine
were determined in the inhalation toxicity study as previously
described (Rustemeier et al., 1993; Haussmann et al., 1998b).
Full necropsy (inhalation toxicity study) was performed with-
out prior fasting on the day following the last day of ex-
posure or post exposure, respectively (Vanscheeuwijck et al.,
2002). The weights of the lungs with larynx and trachea and
of the liver, brain, adrenal glands, testes, kidneys, thymus, and
spleen were determined. Hematological and clinical chemistry
parameters were determined according to standard methods.
Histological sectioning and staining of all OECD-required or-
gans (Organization for Economic Cooperation and Develop-
ment, 1981) with special emphasis on the respiratory-tract or-
gans was performed as described (Terpstra et al., 2003). All
slides were evaluated in a blind manner by a veterinary pathol-
ogist and scored according to a deﬁned grading system (0
= no ﬁnding; 1 = slight; 2 = slight/moderate; 3 = mod-
erate; 4 = moderate/marked; 5 = marked) (Teredesai et al.,
2000).
Analysis of Pulmonary Inﬂammation. Lavage and ﬂow cy-
tometric differentiation of BALF cells was performed as previ-
ouslydescribed(Friedrichsetal.,2006).ViabilityofBALFcells
for all groups was 96% to 97% (SE: 0.3–0.5%); i.e., cell via-
bility was not affected by smoke inhalation. Cells were stained
with the FITC-labeled anti-rat granulocyte monoclonal mouse
antibody, clone HIS48 (BD Biosciences).
Evaluation and Statistics
Arithmetic means and measures of variance were calculated
as descriptive statistics using textbook formulas. Particle size
distribution was calculated by linear regression analysis after
probit transformation (Finney, 1971) of the cumulative frequen-
ciesandlogarithmictransformationoftheaerodynamicdiameter
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To determine 1R4F MS-related effects, the smoke-exposed
groups were compared with the sham-exposed groups. In the
caseofasigniﬁcantresult,thisoverallcomparisonwasfollowed
by a pairwise comparison between the sham-exposed group and
eachofthesmoke-exposedgroups.Forcontinuousdata,analysis
of variance or the Kruskal–Wallis H-test (if at least 1 data point
is below the quantiﬁcation limit) were applied for overall com-
parison followed by Dunnett’s test (Dunnett, 1955). For ordi-
nal data, the Cochran–Mantel–Haenszel test (Koch & Edwards,
1988) was applied for both overall and pairwise comparisons.
To determine EHCSS MS-related effects, the smoke-exposed
groups were compared with the sham-exposed group using the
t-test for continuous data and the Cochran–Mantel–Haenszel
test for ordinal data. In all tests, p values less than or equal to
0.05 were considered to be signiﬁcant (two-tailed). No adjust-
ments for multiple testing were made. Statistically signiﬁcant
resultsshouldbeconsideredasexplorativeindicatorsratherthan
conﬁrmatory evidence.
To assess differences between each EHCSS and the
1R4F, equal effect concentration ratios (EECRs) were deter-
mined (Terpstra et al., 2003) for individual endpoints, if the
concentration-response curve for the 1R4F was signiﬁcantly
different from zero, the mean response of at least one EHCSS
group was signiﬁcantly different from sham, and the mean
response lay between the mean response for sham and the
highest 1R4F group; however, extrapolation of the 1R4F dose-
response curves was made when necessary. To ﬁnd the EECRs,
concentration-response curves were calculated for the sham
and 1R4F groups with least-squares ﬁt to the power function
y = axb +c. Interpolation of the effects of the EHCSS to equal
effects on the 1R4F concentration-response curve indicates
the concentration of MS from the 1R4F needed to produce an
equal effect (for example, see Figure 3). The ratio of these two
concentrations is deﬁned as the EECR,which is reciprocal to
the relative toxicological activity of the two cigarette types. An
EECR of less than 1 means that the toxicological activity of
the EHCSS is lower than that of the 1R4F, and an EECR of
TABLE 1
Characterization of test atmospheres∗: inhalation toxicity study
Parameter Sham 1R4F-low 1R4F-medium 1R4F-high EHC-CaCO3 EHC-AMP
TPM (µg/l) <0.9 79 ± 4 120 ± 5 161 ± 89 0 ± 58 7 ± 5
Particle size, MMAD (µm) – 0.46 0.46 0.47 0.39 0.44
GSD – 1.65 1.66 1.66 1.71 1.78
Carbon monoxide (ppm) <1.5 94 ± 5 141 ± 8 188 ± 9 28.7 ± 0.8 14.5 ± 0.7
Nicotine (µg/l) <0.03 5.9 ± 0.4 8.6 ± 0.6 11.2 ± 1.1 8.3 ± 0.7 7.3 ± 0.6
Formaldehyde (ppm) – 0.12 ± 0.02 0.17 ± 0.03 0.22 ± 0.03 1.32 ± 0.10 0.16 ± 0.03
Acetaldehyde (ppm) – 4.0 ± 0.3 5.9 ± 0.4 7.6 ± 0.6 5.3 ± 0.1 2.9 ± 0.2
Acrolein (ppm) – 0.27 ± 0.03 0.40 ± 0.04 0.52 ± 0.03 0.42 ± 0.03 0.35 ± 0.03
∗Measured at breathing zone in the exposure chambers.
Values represent means ± standard deviations.
MMAD: mass-median aerodynamic diameter; GSD: geometric standard deviation.
more than 1 means that the toxicological activity of the EHCSS
is higher than that of the 1R4F. EECRs assume qualitatively
similar concentration-response curves for all MS types. They
are point estimates, for which no measure of variability can be
determined, but still provide an overview indication of relative
toxicological potency. EECRs can be calculated on the basis of
each MS constituent for which analytical data are available.
RESULTS
Inhalation Toxicity Study: Composition of Diluted
Mainstream Smoke
There was little variation in the composition of the test at-
mospheres for each speciﬁc test sample per condition through-
out the conduct of the study, and TPM concentrations were in
goodcompliancewithtargetconcentrations(Table1).Theparti-
cle size distribution measurements indicated that particles were
equally respirable in all smoke-exposed groups (Table 1). Of
the individual MS constituents determined, only nicotine and
acrolein concentrations in MS from the two EHCs were be-
tween those of 1R4F-low and 1R4F-high. CO was lower for
both EHCs compared to 1R4F-low (−84% for EHC-AMP and
−70% for EHC-CaCO3). Formaldehyde was within the range
of the 1R4F for the EHC-AMP (comparable to 1R4F-medium),
but6timeshigherfortheEHC-CaCO3 comparedto1R4F-high.
Acetaldehyde was lowest for the EHC-AMP (−45% compared
to EHC-CaCO3 and −27% compared to 1R4F-low). The low
CO concentration and relatively high formaldehyde concentra-
tionintheEHC-CaCO3 testatmosphere(comparedtothe1R4F)
havebeenseenbeforeininhalationandanalyticalstudies(Stab-
bert et al., 2003; Terpstra et al., 2003) . The reduction in ac-
etaldehyde and formaldehyde concentrations in MS from the
EHC-AMP to a level comparable to that of 1R4F-medium is
the result of incorporation of AMP in the second-generation
EHC (Roemer et al., 2008). In addition, the use of AMP in
the cigarette paper resulted in a further 49% decrease in CO
concentration.652 O. MOENNIKES ET AL.
TABLE 2
Biomonitoring: inhalation toxicity study
Parameter Sex Sham 1R4F-low 1R4F-medium 1R4F-high EHC-CaCO3 EHC-AMP
Respiratory M 129 ± 8 152 ± 8∗ 128 ± 5 121 ± 4 131 ± 9 125 ± 10
frequency (1/min) F 119 ± 10 146 ± 10 111 ± 79 6 ± 6 100 ± 4 141 ± 5
Average inspiratory M 8.7 ± 0.4 6.2 ± 0.4∗ 5.4 ± 0.6* 5.9 ± 0.4∗ 6.0 ± 0.4∗ 6.7 ± 0.6∗
ﬂow (ml/sec) F 7.1 ± 0.6 5.7 ± 0.6 4.7 ± 0.5∗ 3.9 ± 0.6∗ 4.7 ± 0.4∗ 6.3 ± 0.4
COHb (%) M 0.64 ± 0.03 13.94 ± 0.30∗ 19.5 ± 0.53∗ 26.00 ± 0.65∗ 4.65 ± 0.29∗ 2.27 ± 0.07∗
F 0.85 ± 0.03 12.82 ± 0.33∗ 20.38 ± 1.21∗ 25.27 ± 0.57∗ 4.91 ± 0.40∗ 1.52 ± 0.06∗
Recovery of inhaled M − (n.d.) 73.2 ± 5.3 61.5 ± 6.8 76.0 ± 7.3 63.7 ± 5.7 60.4 ± 7.3
nicotine (%) F − (n.d.) 68.1 ± 9.1 88.3 ± 9.4 75.5 ± 3.9 68.4 ± 11.4 69.6 ± 4.7
Values represent means ± standard error.
∗Statistically signiﬁcantly different from sham, p ≤ 0.05.
n.d.: not determined.
Inhalation Toxicity Study: Biomonitoring
Respiratory parameters, steady-state blood carboxyhe-
moglobin concentration, and nicotine metabolites in urine were
determined and used as biomarkers of exposure (Table 2).
Respiratory Physiology. Respiratory depression in rodent
inhalation studies is a reaction to respiratory-tract irritation
(Alarie, 1973) and is usually concentration dependent in
cigarette smoke inhalation studies (Terpstra et al., 2003).
Average inspiratory ﬂow (AIF) was lower in the 1R4F groups
compared to sham (Table 2). AIF in the EHC-CaCO3 groups
was comparable to that in the 1R4F-low group (males) and
the 1R4F-medium group (females). AIF in the EHC-AMP
group was in the range between sham and the low 1R4F
group, indicating a lower effect of MS from the EHC-AMP
on respiration than MS from the other cigarettes in the study.
While the respiratory frequency was reduced in the groups
exposed to 1R4F MS in a concentration-dependent manner
(both sexes, not statistically signiﬁcant) and the results for the
groups exposed to EHC-AMP or EHC-CaCO3 MS ﬁt into this
concentration-response range, the relevance of this result is
difﬁcult to interpret because the results of the sham-exposed
group did not ﬁt to the typical concentration-response curve
seen in previous studies (Terpstra et al., 2003).
Carboxyhemoglobin. Steady-state concentrations of car-
boxyhemoglobin (COHb) were approximately 5% in the EHC-
CaCO3 group, approximately 2% in the EHC-AMP group, and
upto26%inthe1R4Fhighgroup,thuscorrespondingtotheCO
concentration in the test atmosphere. The results for the 1R4F
are in agreement with historical mainstream smoke inhalation
data from our laboratory (data not shown).
Urinary Nicotine Metabolites. The amount of nicotine
metabolitesexcretedinurinecorrelateswellwiththeestimateof
nicotineinhaled(calculatedfromtherespiratoryminutevolume
[Guyton, 1947], the daily exposure duration, and the nicotine
concentrationindilutedsmoke).Theexcretionofthesemetabo-
lites (60% to 88%, Table 2) was in the range of or higher than
the 60% expected (Schepers et al., 1993). The higher excretion
may suggest that nicotine was taken up not only by inhalation,
but alsoviaotherroutes,suchasoralingestionduringgrooming
(Haussmann et al., 1998b).
In summary, respiratory physiology determinations, COHb-
levels in blood, and urinary nicotine metabolite proﬁles indi-
cate that the rats inhaled MS doses corresponding to the con-
centrations of the representative MS constituents in the test
atmospheres.
Inhalation Toxicity Study: Biological Results
Body Weight. Body weight of all rats increased throughout
the study. At 90 days, body weight was signiﬁcantly lower for
all male smoke-exposed rats compared to sham (from −12%
in the EHC-AMP group to −22% in the EHC-CaCO3 group)
(Figure 2), while females were unaffected (data not shown). At
FIG. 2. Bodyweightdevelopmentofmaleratsinthesubchronic
inhalationtoxicitystudy.Curvesrepresentthemeanbodyweight
of sham- and MS-exposed groups.AMP-DEPENDENT REDUCTION OF EHCSS SUBCHRONIC TOXICITY 653
the end of the 42-day postexposure period, body weight was
still signiﬁcantly lower for male smoke-exposed rats (−11% to
−17% compared to sham, Figure 2). This is due to an unusually
high body weight in male sham-exposed rats. Smoke exposure-
related body weight depression in males and the lack of such an
effect in females has often reported in smoke inhalation stud-
ies of comparable design with Sprague-Dawley rats (Coggins
et al., 1989; Vanscheeuwijck et al., 2002; Terpstra et al., 2003).
Itisconsideredageneralsystemiceffectoftoxicity.Smokecon-
stituents,suchasnicotine(Chowdhuryetal.,1989;Chowdhury,
1990) and acrolein (Bouley et al., 1975; Feron et al., 1978),
have been implicated in this effect. Food consumption normally
correlates with body weight development. The mean food con-
sumptionrelativetobodyweightwas,thus,similarforallgroups
and ranged from 8.0 ± 1.0 to 8.8 ±1.2 g/(100-g rat × day) for
male rats and from 9.3 ± 1.3 to 10.8 ± 1.0 g/(100-g rat × day)
for female rats.
EECRs were obtained by comparing the mean body weight
gain reduction in male rats at the end of the 90-day inhalation
periodforeachoftheEHCSSgroupstotheﬁttedconcentration-
response curve of the 1R4F. EECRs for the reduction in body
weight gain were 2.0 for the EHC-CaCO3 and 0.6 for the EHC-
AMP(Table3),suggestinglesspronouncedbodyweighteffects
by exposure to MS from the EHC-AMP and more pronounced
body weight effects by exposure to MS from the EHC-CaCO3
compared to exposure to MS from the1R4F, when compared on
a TPM basis.
Typical smoke exposure-related ﬁndings were observed dur-
ingtheinhalationperiod.TheseincludedHarderianglandsecre-
tion and effects on spontaneous activity in a few rats, although
there was no difference between groups.
Clinical Chemistry. In the 1R4F groups, concentration-
dependent and statistically signiﬁcant changes compared to
sham were seen for a few parameters in female rats at 90 days;
themostprominentwasanincreaseinalkalinephosphatase(AP)
activity of +96% (Table 4). Most of the effects reversed during
the postexposure period (data not shown).
A comparison of the EHCSS groups with sham revealed no
statistically signiﬁcant differences for male rats, and only a few
for female rats. Of the four statistically signiﬁcant differences
seen for the EHC-CaCO3 group, the most prominent was for
AP activity (+102%). The single statistically signiﬁcant differ-
ence seen in the EHC-AMP group was a slight decrease in total
cholesterolconcentration(−22%).Mosteffectshadreversedby
the end of the postexposure period (data not shown). In general,
these effects lacked any correlation to pathological ﬁndings in
major organs, such as the liver or kidney, and were thus not con-
sidered to be toxicologically relevant or to adversely affect the
healthstatusoftherats.Comparablechangeshavebeenobserved
in other smoke inhalation studies (Vanscheeuwijck et al., 2002;
Terpstra et al., 2003) and are thought to reﬂect differences in
the nutritional status of smoke-exposed rats and the inﬂuence of
smoke exposure on lipid metabolism (Latha et al., 1988; Maida
&H o wlett, 1990).
Mean EECRs for clinical parameters for female rats were
1.6 for the EHC-CaCO3 and 0.8 for the EHC-AMP (Table 4).
These EECRs may indicate on average a slightly lower impact
byexposuretoMSfromtheEHC-AMPthanbyexposuretoMS
from the EHC-CaCO3 or the 1R4F, when compared on a TPM
basis.
Hematology. Red blood cell (RBC) parameters (data not
shown) and platelet counts for all groups were within the range
of values for untreated rats given by the breeder, while a trend
towardslowerplateletcountswasseeninsmoke-exposedgroups
(Table 3). The total white blood cell (WBC) count was lower in
male smoke-exposed rats compared to sham (data not shown),
which is in accordance with our previous MS inhalation studies
(Vanscheeuwijck et al., 2002). In females, the WBC count was
slightly higher in all smoke-exposed groups compared to sham;
however, some of the sham values obtained were unusually low
compared to those given by the breeder for untreated rats (data
not shown). Histopathological examination of the bone-marrow
(data not shown) did not reveal any changes that could explain
this lower total WBC count in these rats.
With regard to the differential WBC count, a concentration-
dependent increase in segmented neutrophils and decrease in
lymphocytes was observed (Table 3) in the smoke-exposed
groups (not statistically signiﬁcant in all groups). This is similar
to ﬁndings in previous MS inhalation studies in our laboratories
(Vanscheeuwijck et al., 2002; Terpstra et al., 2003), but was not
seen by others (Coggins et al., 1989; Gaworski et al., 1997).
Exposure to cigarette smoke has been reported to promote the
release of neutrophils from bone marrow into the peripheral
blood (Terashima et al., 1997, 1999) and in humans is associ-
ated with increased neutrophilic chemotactic activity (Ander-
son et al., 1991). EECRs for hematological parameters were 1.4
(males) and 1.3 (females) for the EHC-CaCO3 and 1.7 (males)
and 0.6 (females) for the EHC-AMP, which is an inconclusive
response due to the large variation of the EECRs.
At the end of the 42-day postexposure period, no signiﬁcant
differences were seen between the sham and smoke-exposed
groups for RBC parameters, total WBC count, and differential
WBC count, indicating complete recovery (exception: slight in-
crease in platelet count in female rats exposed to MS from the
EHC-CaCO3, which is considered a chance ﬁnding; data not
shown).
Gross Pathology. Typical smoke-related ﬁndings, such as
discoloration of the fur and thymus atrophy (Vanscheeuwijck
et al., 2002), were seen, along with a variety of incidental ﬁnd-
ings (data not shown). Only discoloration of the fur was still
seen at the end of the postexposure period.
Organ Weights. Relative organ weights (data not shown)
were higher at 90 days for lungs (up to +38%, males only),
adrenals (up to +66%), and kidneys (up to +19%, males only),
andlowerforthymus(upto−58%).Thesechangesareinaccor-
dance with published data (Huber et al., 1981; Coggins et al.,
1989; Vanscheeuwijck et al., 2002; Terpstra et al., 2003) and
are considered to be caused by smoke-related irritation andT
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exposure-related stress. The increase in adrenal weight might
well be an effect of nicotine (Boelsterli et al., 1984). Almost
all organ weight changes had recovered completely by the end
of the 42-day postexposure period, although thymus atrophy
data were inconsistent. Mean EECRs for relative organ weights
were 1.8 (males) and 1.6 (females) for the EHC-CaCO3 and 0.4
(males) and 0 (females) for the EHC-AMP, suggesting lower
toxicological impact by exposure to MS from the EHC-AMP
andslightlyhighertoxicologicalimpactbyexposuretoMSfrom
the EHC-CaCO3 compared to that of the 1R4F, when compared
on a TPM basis.
Histopathology of Respiratory-Tract Organs (Table 5).
In the nose, the histopathological changes observed in all
smoke-exposed groups included reserve-cell hyperplasia of the
respiratory epithelium on the lateral wall, the nasoturbinates,
and the maxilloturbinates; goblet-cell hyperplasia and squa-
mous metaplasia accompanied by the loss of goblet cells in the
septal region of the anterior nose section (level 1, immediately
posterior to the incisor teeth); reserve-cell hyperplasia of the
respiratory epithelium and atrophy (Figure 3) and squamous
metaplasiaoftheolfactoryepitheliumatnoselevel2(atincisive
papilla); and atrophy and squamous metaplasia of the olfactory
epithelium at nose level 3 (at the second palatal ridge) and nose
level 4 (at the ﬁrst upper molar teeth). Mean EECRs for the
nose were 1.4 (males) and 1.5 (females) for the EHC-CaCO3
FIG. 3. EECR estimation for atrophy of olfactory epithelium in
the olfactory region of the nose at level 2. Male rats at the end of
theinhalationperiodofthesubchronicinhalationtoxicitystudy.
Data points with error bars (mean values with SE) represent the
scoring of histopathological ﬁndings for the different exposure
groups. For the 1R4F cigarette the concentration response curve
is plotted on a µg TPM/L basis. Arrows indicate the estimation
of the concentration of 1R4F MS causing an effect compara-
ble to the one of the EHC MS. The EECR is calculated by di-
viding the corresponding 1R4F concentration through the EHC
concentration.
and 0.2 (males) and 0.4 (females) for the EHC-AMP, indicative
of lower nasal irritant effects from exposure to MS from the
EHC-AMP and slightly higher irritative effects from exposure
to MS from the EHC-CaCO3 compared to that of 1R4F, when
compared on a TPM basis.
In the larynx, hyperplasia of the squamous epithelium was
observed in smoke-exposed rats ventromedially at the base of
the epiglottis, at the vocal cords lower medial region, and at
the vocal folds. Additional ﬁndings included hyperplasia and
squamous metaplasia of the cuboidal epithelium at the ventral
depression; hyperplasia of the pseudostratiﬁed epithelium at the
vocal cords (upper medial region); and squamous metaplasia
of the pseudostratiﬁed epithelium ventrolaterally, at the base of
the epiglottis, at the ﬂoor of the larynx, and at the vocal cords
upper medial region. Morphometrical determinations showed
increased epithelial thickness at the ventral depression, ﬂoor
of the larynx, and vocal cords. Mean EECRs for the larynx
were 0.8 (males) and 0.9 (females) for the EHC-CaCO3 and
1.3 (males) and 1.1 (females) for the EHC-AMP. These EECRs,
calculatedonaTPMbasis,inconcordancewiththemorphologic
and morphometric data, suggest minimal differences between
the effects of the MS from the two generations of EHC and that
of the 1R4F, although with an indication of a slightly higher
toxicological impact for MS from the EHC-AMP compared to
the EHC-CaCO3 and the 1R4F.
In the trachea, minimal reserve-cell hyperplasia and goblet-
cell hyperplasia were observed in smoke-exposed rats. The left
lung showed goblet-cell hyperplasia of the bronchial epithelium
and accumulation of pigmented alveolar macrophages in the
alveolar lumen. EECRs for the lung were 1.2 (males) and 1.5
(females) for EHC-CaCO3 and 0 (males) and 0.8 (females) for
the EHC-AMP, again indicative of lower toxicological potency
for MS from the EHC-AMP and slightly higher potency for MS
from the EHC-CaCO3 MS compared to that of the 1R4F, when
compared on a TPM basis.
At the end of the 42-day postexposure period, the goblet-cell
hyperplasia in the anterior nose was slightly higher than at the
endofthe90-dayexposureperiod.Thishasbeenobservedinear-
lierstudiesandhasalsobeenreportedintheliterature(Harkema
etal.,1989;Hotchkissetal.,1995).Mostotherﬁndingsreversed
completely or nearly completely, except for reserve-cell hyper-
plasia and squamous metaplasia of the respiratory epithelium in
theanteriornose(1R4FandEHC-CaCO3),atrophyoftheolfac-
tory epithelium in the posterior nose (1R4F and EHC-CaCO3),
and hyperplasia of the squamous epithelium at the vocal cords
(all groups). This is consistent with recovery effects seen in
previous studies, suggesting that the MS exposure-related mor-
phological changes are predominantly adaptive, reversible re-
sponses to repeated irritation (Burger et al., 1989).
Histopathology of Non-Respiratory-Tract Organs. No
histopathologicaleffectwasseeninnon-respiratory-tractorgans
andtissues,apartfromaminimaltomoderateinvolution/atrophy
of the thymus in smoke-exposed groups, as indicated by the
lower thymus weight. Laboratory animal thymus atrophy via656 O. MOENNIKES ET AL.
TABLE 5
Histopathology of respiratory tract organs after 90 days of exposure: inhalation toxicity study
Scores of histopathological ﬁndings and laryngeal epithelial thickness
EECRs
Groups
Parameter Sex Sham 1R4F-low 1R4F-medium 1R4F-high EHC-CaCO3 EHC-AMP
EHC-
CaCO3
EHC-
AMP
Nose, level 1
Reserve cell hyperplasia M 0.0 ± 0.0 4.0 ± 0.0* 4.0 ± 0.0* 4.0 ± 0.0* 4.0 ± 0.0* 3.1 ± 0.4* – –
(respiratory epithelium) F 0.0 ± 0.0 2.2 ± 0.2* 2.6 ± 0.3* 3.6 ± 0.3* 2.4 ± 0.3* 2.0 ± 0.0* 1.07 0.85
Goblet cell hyperplasia M 0.0 ± 0.0 0.6 ± 0.2* 1.3 ± 0.2* 1.5 ± 0.2* 0.2 ± 0.1 0.4 ± 0.2* 0.34 0.62
(respiratory epithelium) F 0.0 ± 0.0 0.4 ± 0.2* 0.4 ± 0.2* 0.7 ± 0.2* 0.1 ± 0.1 0.1 ± 0.1 – –
Loss of goblet cells M 0.0 ± 0.0 0.7 ± 0.2* 1.6 ± 0.2* 1.5 ± 0.2* 1.9 ± 0.2* 0.1 ± 0.1 – –
(respiratory epithelium) F 0.0 ± 0.0 0.7 ± 0.2* 1.6 ± 0.3* 1.8 ± 0.1* 1.3 ± 0.2* 0.2 ± 0.1 – –
Squamous metaplasia) M 0.0 ± 0.0 1.3 ± 0.5* 3.1 ± 0.1* 2.5 ± 0.4* 2.9 ± 0.1* 0.7 ± 0.4 1.85 0.22
(respiratory epithelium) F 0.4 ± 0.4 0.3 ± 0.3 2.3 ± 0.5* 1.8 ± 0.6* 1.1 ± 0.4 0.0 ± 0.0 – –
Nose, level 2
Reserve cell hyperplasia M 0.0 ± 0.0 0.0 ± 0.0 0.9 ± 0.5 1.7 ± 0.3* 1.1 ± 0.5* 0.0 ± 0.0 1.48 0.43
(respiratory epithelium) F 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.3 ± 0.3 0.0 ± 0.0 0.0 ± 0.0 – –
Atrophy M 0.0 ± 0.0 0.7 ± 0.4 1.8 ± 0.6* 4.0 ± 0.0* 2.9 ± 0.6* 0.0 ± 0.0 1.6 0
(olfactory epithelium) F 0.0 ± 0.0 0.2 ± 0.2 2.9 ± 0.5* 3.7 ± 0.3* 3.2 ± 0.3* 0.3 ± 0.2 1.62 0.58
Squamous metaplasia M 0.0 ± 0.0 0.0 ± 0.0 1.0 ± 0.5 2.1 ± 0.5* 0.7 ± 0.4 0.0 ± 0.0 – –
(olfactory epithelium) F 0.0 ± 0.0 0.1 ± 0.1 1.4 ± 0.4* 1.3 ± 0.2* 1.1 ± 0.1* 0.0 ± 0.0 1.47 0.22
Nose, level 3
Atrophy M 0.0 ± 0.0 0.4 ± 0.4 1.6 ± 0.6* 4.0 ± 0.0* 2.2 ± 0.7* 0.0 ± 0.0 1.49 0.36
(olfactory epithelium) F 0.0 ± 0.0 0.4 ± 0.4 3.0 ± 0.4* 3.8 ± 0.2* 3.2 ± 0.3* 0.0 ± 0.0 1.59 0.26
Squamous metaplasia M 0.0 ± 0.0 0.3 ± 0.3 1.0 ± 0.5 3.0 ± 0.0* 2.0 ± 0.5* 0.0 ± 0.0 1.61 0
(olfactory epithelium) F 0.0 ± 0.0 0.2 ± 0.2 1.3 ± 0.3* 2.0 ± 0.2* 1.2 ± 0.2* 0.0 ± 0.0 1.39 0.32
Nose, level 4
Atrophy M 0.0 ± 0.0 0.2 ± 0.2 0.7 ± 0.3 2.0 ± 0.0* 1.1 ± 0.4* 0.0 ± 0.0 1.52 s0
(olfactory epithelium) F 0.0 ± 0.0 0.1 ± 0.1 1.6 ± 0.2* 1.9 ± 0.1* 1.6 ± 0.2* 0.0 ± 0.0 1.57 0.31
Squamous metaplasia M 0.0 ± 0.0 0.3 ± 0.3 1.0 ± 0.5 3.0 ± 0.0* 1.7 ± 0.5* 0.0 ± 0.0 1.52 0
(olfactory epithelium) F 0.0 ± 0.0 0.1 ± 0.1 1.4 ± 0.3* 1.6 ± 0.2* 1.5 ± 0.4* 0.0 ± 0.0 1.68 0.28
Larynx, base of epiglottis M 0.0 ± 0.0 4.7 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* – –
Squamous metaplasia
(pseudostratiﬁed
epithelium)
F 0.0 ± 0.0 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* – –
Hyperplasia M 0.0 ± 0.0 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* – –
(Squamous epithelium) F 0.0 ± 0.0 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* 5.0 ± 0.0* – –
Arytenoid projections,
ventral depression
squamous metaplasia
(cuboidal epithelium)
M 0.0 ± 0.0 0.9 ± 0.3* 1.1 ± 0.4* 2.3 ± 0.6* 0.9 ± 0.4* 0.9 ± 0.3* 1.03 1.06
F 0.0 ± 0.0 0.7 ± 0.4 2.4 ± 0.6* 3.2 ± 0.6* 0.7 ± 0.4 1.2 ± 0.4* 0.73 1.02
Arytenoid projections,
vocal cords, lower
medial region
hyperplasia (squamous
epithelium)
M 0.0 ± 0.0 2.3 ± 0.2* 2.9 ± 0.2* 2.4 ± 0.2* 2.3 ± 0.2* 2.8 ± 0.2* – –
F 0.0 ± 0.0 3.0 ± 0.3* 2.3 ± 0.3* 2.8 ± 0.3* 2.0 ± 0.3* 3.2 ± 0.2* – –
Arytenoid projections,
vocal cords, upper
medial region
Squamous metaplasia
(pseudostratiﬁed
epithelium)
M 0.0 ± 0.0 2.0 ± 0.4* 2.6 ± 0.7* 2.9 ± 0.4* 1.0 ± 0.2* 2.1 ± 0.4* 0.23 0.99
F 0.0 ± 0.0 4.6 ± 0.2* 3.3 ± 0.4* 3.4 ± 0.3* 3.3 ± 0.7* 3.3 ± 0.6* – –
Arytenoid projections,
ﬂoor of the larynx
Squamous metaplasia
(pseudostratiﬁed
epithelium)
M 0.0 ± 0.0 4.6 ± 0.3* 5.0 ± 0.0* 4.8 ± 0.2* 4.8 ± 0.2* 4.8 ± 0.2* – –
F 0.0 ± 0.0 4.2 ± 0.6* 4.8 ± 0.2* 5.0 ± 0.0* 5.0 ± 0.0* 4.8 ± 0.2* – –
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TABLE 5
Histopathology of respiratory tract organs after 90 days of exposure: inhalation toxicity study
Scores of histopathological ﬁndings and laryngeal epithelial thickness (Continued)
EECRs
Groups
Parameter Sex Sham 1R4F-low 1R4F-medium 1R4F-high EHC-CaCO3 EHC-AMP
EHC-
CaCO3
EHC-
AMP
Arytenoid projections,
vocal folds
Hyperplasia
M 0.0 ± 0.0 0.8 ± 0.2* 1.4 ± 0.2* 1.5 ± 0.2* 0.7 ± 0.3* 1.2 ± 0.3* 0.62 1.35
F 0.0 ± 0.0 1.2 ± 0.2* 1.0 ± 0.1* 1.1 ± 0.1* 0.9 ± 0.1 1.2 ± 0.2* – –
(squamous epithelium)
Tracheal bifurcation
reserve cell hyperplasia
(respiratory epithelium)
M 0.0 ± 0.0 0.0 ± 0.0 0.0 ± 0.0 0.1 ± 0.1 0.0 ± 0.0 0.0 ± 0.0 – –
goblet cell hyperplasia
(respiratory epithelium)
M 0.0 ± 0.0 0.3 ± 0.2 0.4 ± 0.3 0.9 ± 0.4 0.3 ± 0.2 0.1 ± 0.1 – –
goblet cell hyperplasia
(respiratory epithelium)
F 0.2 ± 0.1 0.3 ± 0.2 0.9 ± 0.3 0.4 ± 0.3 0.4 ± 0.2 0.2 ± 0.1 – –
Left lung
Goblet cell hyperplasia M 0.6 ± 0.6 2.9 ± 0.5* 3.0 ± 0.5* 3.3 ± 0.5* 3.0 ± 0.5* 0.9 ± 0.4 1.16 0
(respiratory epithelium) F 0.4 ± 0.3 1.2 ± 0.6 2.3 ± 0.6* 3.2 ± 0.6* 2.6 ± 0.7* 1.2 ± 0.6 1.53 0.83
Alveolar macrophages M 0.0 ± 0.0 0.8 ± 0.1* 1.0 ± 0.2* 1.3 ± 0.2* 0.3 ± 0.2 0.1 ± 0.1 – –
(respiratory epithelium) F 0.0 ± 0.0 0.3 ± 0.2 0.7 ± 0.2* 1.3 ± 0.2* 0.1 ± 0.1 0.0 ± 0.0 – –
Larynx
ventral M 7.73 ± 0.45 11.16 ± 0.68 11.66 ± 0.70* 14.72 ± 1.74* 11.61 ± 0.98* 11.85 ± 0.78* 1.14 1.23
depression (µm) F 7.95 ± 0.47 10.56 ± 0.71 15.74 ± 1.63* 16.54 ± 1.01* 11.22 ± 0.78* 11.88 ± 1.09* 0.80 0.95
ﬂoor of the M 9.56 ± 0.34 17.51 ± 1.24* 24.74 ± 0.53* 21.67 ± 2.37* 20.64 ± 1.74* 22.73 ± 1.57* 1.17 1.72
larynx (µm) F 8.62 ± 0.11 18.97 ± 1.18* 23.52 ± 1.51* 29.29 ± 1.61* 20.44 ± 1.29* 24.68 ± 1.64* 1.04 1.45
vocal cords (µm) M 18.66 ± 1.11 29.39 ± 1.28* 34.39 ± 1.38* 32.21 ± 0.89* 29.51 ± 1.55* 32.65 ± 1.22* – –
F 17.42 ± 1.55 33.16 ± 0.94* 32.33 ± 1.22* 34.03 ± 1.02* 31.93 ± 1.25* 34.91 ± 1.44* – –
Values represent means ± standard error.
*Statistically signiﬁcantly different from sham, p ≤ 0.05.
EECRs were calculated on an equal TPM basis.
–: no EECR calculated because data did not ﬁt the criteria.
CD4+CD8+ lymphocyte apoptosis has been associated with
any type of stress, such as restraint, irritation, trauma, or so-
cialstress,whichismediatedbyglucocorticoidreleasefromthe
adrenal cortex (Warholm et al., 1984; Nakanishi et al., 1998;
Dal-Zotto et al., 2003; Rodrigues-Mascarenhas et al., 2006).
TABLE 6
Characterization of test atmospheres*: pulmonary inﬂammation study
Parameter Sham 1R4F-450a 1R4F-600a EHC-AMP-750a
TPM (µg/l) <4.0 448 ± 30 603 ± 41 739 ± 38
Carbon monoxide (ppm) <1.5 505 ± 34 656 ± 47 74.1 ± 5.4
Nicotine (µg/l) <0.11 31 ± 2.0 41 ± 3.1 65.1 ± 3.1
Formaldehyde (ppm) – 0.58 ± 0.04 0.75 ± 0.05 0.83 ± 0.17
Acetaldehyde (ppm) – 20 ± 0.6 27 ± 20 18 ± 1.2
Acrolein (ppm) – 1.5 ± 0.1 1.9 ± 0.1 2.0 ± 0.10
∗Measured at breathing zone in the exposure chambers.
Values represent means ± standard deviations.
aTarget TPM concentration (µg/l).
Pulmonary Inﬂammation Study
The pulmonary inﬂammation study was designed to com-
plement the inhalation toxicity study with lung inﬂammation
data. A limited number of quality control parameters were de-
termined, e.g., for biomonitoring.658 O. MOENNIKES ET AL.
TABLE 7
Differentiation of BALF cells after 90 days of exposure: pulmonary inﬂammation study
Groups
Parameter Sham 1R4F-450 1R4F-600
EHC-
AMP-750
EECR
EHC-AMP-750
FLC number(106) 12.6 ± 0.8 16.7 ± 0.7* 17.0 ± 0.8* 15.6 ± 0.6 –
Alveolar macrophages (106) 12.5 ± 0.7 14.9 ± 0.7 14.0 ± 0.9 14.9 ± 0.6* –
Alveolar macrophages (%) 99.0 ± 0.1 89.2 ± 1.4* 82.1 ± 2.2* 95.5 ± 0.8* –
Neutrophils (106) 0.04 ± 0.008 1.70 ± 0.283* 2.76 ± 0.301* 0.63 ± 0.118* 0.33
Neutrophils (%) 0.35 ± 0.05 10.13 ± 1.42* 16.80 ± 2.14* 3.99 ± 0.73* 0.35
Lymphocytes (106) 0.08 ± 0.012 0.11 ± 0.007 0.18 ± 0.02* 0.078 ± 0.007 –
Lymphocytes (%) 0.65 ± 0.10 0.67 ± 0.05 1.10 ± 0.15* 0.50 ± 0.05 –
Values represent means ± standard error.
*Statistically signiﬁcantly different from sham, p ≤ 0.05.
EECRs calculated on an equal TPM basis.
-: no EECR calculated.
Composition of Diluted Mainstream Smoke. The MS com-
positionfortheEHC-AMPand1R4Finthisinﬂammationstudy
(Table 6) corresponded well to that observed in the inhalation
toxicity study (Table 1).
Biomonitoring. The decrease in respiratory frequency and
theincreaseincarboxyhemoglobinconcentrationshowedaclear
concentration response (data not shown). As in the inhalation
toxicity study, the biomonitoring parameters indicated that the
rats inhaled increasing doses with increasing smoke concentra-
tions in the test atmospheres.
Inﬂammation. A statistically signiﬁcant increase in the ab-
solute and relative number of neutrophils in BALF (a main
indicator of pulmonary inﬂammation) was found in all smoke-
exposed groups compared to sham in the pulmonary inﬂamma-
tion study. Similar responses have been seen in other cigarette
smoke inhalation studies in rodents (Gairola, 1986; Mordelet-
Dambrine et al., 1991; Balansky et al., 1992) and have been at-
tributed to the inhalation of the particulate phase of MS in these
models (Friedrichs et al., 2006). The increase in neutrophils
showed a clear concentration-response relationship in the 1R4F
groups (Table 7 and Figure 4). The number of neutrophils was
considerably lower in the EHC-AMP group compared to the
1R4F groups (Table 7 and Figure 4).
Other exposure-related changes in BALF were increases in
the absolute number of alveolar macrophages, the absolute and
relative number of lymphocytes, and the total number of free
bronchoalveolar cells, and a decrease in the relative number
of alveolar macrophages. The concentration-response effect for
these parameters was relatively weak compared to the neu-
trophils, as observed in other MS inhalation studies (Friedrichs
et al., 2006). Therefore, only neutrophils were used for EECR
calculations, i.e., 0.3 and 0.4 for absolute and relative number
of neutrophils, respectively, which suggests that MS from the
EHC-AMP has approximately one-third the inﬂammatory po-
tential of MS from the 1R4F.
DISCUSSION
One strategy to reduce the adverse biological effects of MS
is to reduce the yield of certain toxic smoke constituents by
generating smoke at temperatures below those found in conven-
tional cigarettes (Patskan & Reininghaus, 2003). The EHCSS,
consisting of an electronically controlled heater/lighter device
andspeciallydesignedcigarettes,putsthisconceptintopractice.
While chemical analysis and in vitro and in vivo testing of MS
FIG. 4. EECR estimation for the relative number of BALF neu-
trophils in the inﬂammation study. Data points with error bars
(mean values with SE of indicated exposure groups) represent
percentage of neutrophils in free lung cells determined after
35 days of exposure. For the 1R4F the concentration response
curve is plotted on a µg TPM/L basis. Arrows indicated the
estimation of the concentration of 1R4F MS causing an effect
comparable to the one of the EHC MS. The EECR is calculated
by dividing the corresponding 1R4F concentration through the
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produced by the ﬁrst generation of this system showed at least a
partial reduction in yield of smoke constituents and toxic activ-
ity,italsodiscoveredastrongincreaseinformaldehydeyield.To
address this increase in formaldehyde, the second generation of
EHCSS was developed with AMP in the cigarette paper. Chem-
ical analysis of MS from the EHCSS with AMP showed lower
yields not only of formaldehyde, but also of several other toxic
tobacco smoke constituents, although there were also increases
inammoniaandHMTyields(Roemeretal.,2008).TheEHCSS
without AMP was already characterized by a strong reduction
in CO, which is considered to be a risk factor for cardiovascu-
lar diseases (U.S. Department of Health and Human Services,
2004).IncorporationofAMPresultedinanevenfurtherdecrease
in CO (Tables 1 and 6). Other potentially beneﬁcial effects of
AMP were seen for most of the in vitro parameters determined
in cytotoxicity and mutagenicity assays (Roemer et al., 2008),
which are complemented by the results of the inhalation studies
presented here.
In contrast to the in vitro assays, which yield data related
to speciﬁc endpoints, such as genotoxicity or cytotoxicity, the
inhalation studies yield a more diverse set of data considering
biological interaction in an in vivo model. To unify this diver-
sityofmeasurementsandcreateacommonbasisforcomparison
of cigarettes, we use equal effect concentration ratios (EECRs)
(Terpstraetal.,2003).TheEECRsinthepresentstudyarecalcu-
lated from the TPM concentration of the conventional reference
cigarette divided by the concentration of the test cigarette at an
equal effect level. Any other smoke constituent could as well
be used as a measure for the MS concentration and the basis
for comparison between test atmospheres. An EECR of lower
than 1 indicates that the biological activity of MS from the test
cigarette is lower than that of MS from the conventional refer-
encecigarette,notwithstandingthelimitsgivenbydatavariabil-
ity.Likewise,anEECRofhigherthan1meansthatthebiological
activity of the EHC is greater than that of the 1R4F.
TheEECRsonaTPMbasisobtainedinthisstudyareslightly
overestimated based on the differential composition and the re-
sulting differential behavior of the EHCSS and conventional
cigarette MS upon dilution in the exposure system as previously
discussed (Terpstra et al., 2003). For example, the water con-
centration is generally around 10% in MS from conventional
cigarettes, but around 30% in MS from the EHCSS (Stabbert
et al., 2003; Roemer et al., 2004). In our experimental setup,
MS is diluted between the site of smoke production (smoking
machine)andthesiteofTPMsamplecollection(exposurecham-
ber at the breathing zone of the rats, Figure 1). When the MS
is diluted, the mass of the EHCSS smoke particulate matter de-
creases more than that of conventional cigarettes because of the
partial evaporation of more abundant semi-volatile constituents,
including water, glycerol, and nicotine. Thus, compared to the
nominal TPM yield in undiluted MS, the TPM mass measured
inthebreathingzoneoftheratsisartiﬁciallymoredecreasedfor
theEHCSSthanforaconventionalcigarette,whichinturnleads
to an overestimation of EECR values relative to the true ones,
which would be based on the nominal TPM yields. This is of
toxicological relevance because the rats were exposed to whole
smoke, which contains an artiﬁcially increased concentration
of potentially irritating constituents in the gas phase relative to
TPM in MS from the EHCSS compared to that of MS from
conventional cigarettes.
A major point of interest in any inhalation toxicity study is
the histopathological examination of the respiratory tract. Over-
all, MS from EHC-AMP, as indicated by the mean EECRs for
histopathologicalﬁndingsinthenose,larynx,andlungs,showed
al o wer potency than that of the 1R4F (0.5 for males and 0.8
for females). In contrast, the potency of the EHC-CaCO3 (1.1
for males and 1.3 for females) was found to be slightly higher
than that of the 1R4F. For the EHC-CaCO3, this compares well
to an overall EECR of 1.0 obtained for the ﬁrst generation of
EHCSS compared to the conventional reference cigarette 1R4F
(Terpstra et al., 2003). However, unlike the results obtained for
the ﬁrst-generation EHCSS, the EECRs obtained in the current
study for the different parts of the respiratory tract do not re-
veal a uniform pattern for the two types of EHC. Findings in the
anterior (nose) and posterior (lung) part of the respiratory tract
showed considerably lower EECRs for the EHC-AMP, whereas
the EECR for the larynx was somewhat higher than 1. For the
EHC-CaCO3,theresultsarejusttheopposite,showinganEECR
ofslightlylessthan1forthelarynxbutgreaterthan1fortheother
respiratory-tractorgans(Figure5).Laryngealeffectsaremainly
particulate-phase effects (Coggins et al., 1980; Friedrichs et al.,
2006), although neither the TPM concentration nor the parti-
cle size distribution could explain these differences in laryngeal
responses. One possible explanation might be that particle de-
positionisgreaterinthelaryngesofratsexposedtoMSfromthe
EHC-AMP because of the lower irritant potency of the smoke:
Formaldehyde and acrolein are examples of gas-phase irritants
whose concentrations were reduced in MS by the incorporation
of AMP in the EHC cigarette paper. Both formaldehyde and
acrolein, individually as well as in mixtures, are known to cause
irritation in rats (Feron et al., 1978; Cassee et al., 1996) at the
concentrations found in MS from the EHC-CaCO3. Despite the
reductions achieved by the incorporation of AMP in the EHC
cigarettepaper,theacroleinconcentrationinMSfromtheEHC-
AMP seen in the inhalation toxicity study is still slightly above
thethreshold(0.2ppm)foracuteirritationeffects(Roemeretal.,
1993). Rodents (like humans) can adapt their breathing patterns
toaccommodateexposuretoirritants,andwithlessirritation,the
inspiratory ﬂow might be less depressed, thus leading to higher
particle deposition through impaction in the larynx. This theory
is supported by plethysmographic data, showing a higher aver-
ageinspiratoryﬂowinfemaleratsandacorrespondingtrendfor
theseeffectsinmaleratsintheEHC-AMPgroups(Table2).Dis-
tinctly decreased histopathological ﬁndings in the nose, which
are considered to be mainly affected by the gas phase (Coggins
et al., 1980; Gaworski et al., 1998; Friedrichs et al., 2006), also
indicate that MS from the EHC-AMP has less irritating activity
in this part of the respiratory tract.660 O. MOENNIKES ET AL.
FIG. 5. Subchronic inhalation toxicity effects of the EHC compared to the 1R4F. Summarized EECRs on a µg TPM/L basis from
male and female rats for different end points combined under common toxicological perspectives. An EECR of below 1 indicates
that the activity of the cigarette tested is less than that of the 1R4F.
One characteristic pathological change induced by cigarette
smoke exposure in humans and experimental animals is the ac-
cumulation of inﬂammatory cells in the lung (Hoidal & Jeffery,
1998; Barnes, 2000). This pulmonary inﬂammation can lead to
COPD if the normal protective and/or repair mechanisms of the
lungareoverwhelmedordefective(GlobalInitiativeforChronic
Obstructive Lung Disease, 2001). Moreover, the degree of in-
ﬂammation in the lung parenchyma correlates with the severity
of alveolar septal damage in autopsy and surgical specimens
(Eidelman et al., 1990; Finkelstein et al., 1995; Saetta, 1999).
In animal studies, the main indication of cigarette-smoke in-
duced pulmonary inﬂammation is an increase in the propor-
tion and number of neutrophils counted in lung slides or BALF
(Gairola,1986;Mordelet-Dambrineetal.,1991;Balanskyetal.,
1992;Marchetal.,1999,2002).Thisincreasedneutrophilnum-
ber has also been observed in induced sputum from human
smokers,whileCOPDpatientsshowedafurtherincreaseinneu-
trophils (Keatings et al., 1996). In the pulmonary inﬂammation
study, a clear concentration response of BALF neutrophils was
found for the 1R4F. Overall, the neutrophil numbers in BALF
showed the inﬂammatory activity of MS from the EHC-AMP to
beapproximatelyone-thirdthatofthe1R4F(Table7andFigure
5). The determination of free lung cells in BALF is, therefore, a
sensitive and speciﬁc addition to the usual end points according
to OECD guideline 413, when assessing the inhalation toxicity
of cigarette smoke.
Changes in relative organ weights as a whole showed an
EECR of below 1 for the rats exposed to MS from the EHC-
AMP. A combined EECR of below 1 was also found for the
EHC-AMP for clinical chemistry and reduction in body weight
gain(maleratsonly),whiletheEECRforhematologicalactivity
wasinconclusive.Thechangesinthreeofthesefourparameters,
which are often indicators of systemic effects, were lower after
exposure to MS from the EHC-AMP than after exposure to MS
from the EHC-CaCO3 or the 1R4F (Figure 5).
The addition of AMP to the cigarette paper of the EHC in-
creased the MS yield of ammonia and HMT, a condensation
product of formaldehyde and ammonia (Roemer et al., 2008),
and might well have increased the yield of other still unknown
products. However, the results of the current in vivo studies,
which utilize the broad pathological evaluation suggested by
OECD guideline 413, in combination with the parallel chemical
analytical and in vitro studies (Roemer et al., 2008) do not raise
any toxicological concern in this regard.
The addition of AMP to the cigarette paper of the EHC
reduced not only the yield and thus the MS concentration
of formaldehyde, but also the yields of other smoke con-
stituents (Roemer et al., 2008), including other aldehydes. In-
haled formaldehyde, acetaldehyde, and acrolein are absorbed
and react mainly in the nose of exposed rodents (Leach et al.,
1987; Wilmer et al., 1989; Morris, 1997). Consequently, the
most pronounced decreases in irritative potency were observedAMP-DEPENDENT REDUCTION OF EHCSS SUBCHRONIC TOXICITY 661
TABLE 8
Overview of equal effect concentration ratios for
histopathological ﬁndings after 90 days of exposure: inhalation
toxicity study
EECRs
Basis of
comparison
Histopathological
ﬁnding Sex EHC-CaCO3 EHC-AMP
TPM (µg/l) Nose M 1.43 0.20
F 1.48 0.40
Larynx M 0.63 1.13
F 0.73 1.02
Lung M 1.16 0
F 1.53 0.83
Cigarette Nose M 0.47 0.05
(cig./m3)F 0.48 0.12
Larynx M 0.20 0.35
F 0.23 0.30
Lung M 0.38 0
F 0.50 0.26
Nicotine Nose M 1.09 0.17
(µg/l) F 1.16 0.38
Larynx M 0.51 0.98
F 0.60 0.89
Lung M 0.91 0
F 1.17 0.75
Mean of combined ﬁndings for each organ.
in the nasal cavity of rats exposed to MS from the EHC with
AMP in the cigarette paper compared to those exposed to MS
fromtheEHCwithoutAMP.However,onlysmallpercentagesof
these aldehydes reach the lungs upon inhalation. Nevertheless,
there is a substantial decrease in the potency of EHC MS to in-
duce bronchial goblet-cell hyperplasia with AMP incorporated
in the cigarette paper. Even more pronounced is the reduction
in pulmonary inﬂammatory potency following inhalation of MS
from the EHC-AMP. This is even more noteworthy, since the
already-mentioned aldehydes occur mainly in the gas phase of
MS, which could not induce pulmonary inﬂammation in this rat
inhalation model (Friedrichs et al., 2006). Thus, incorporation
ofAMPinthecigarettepaperreducedthetoxicologicalpotency
of EHC more than expected based on the intended reduction in
formaldehyde yield.
Inprinciple,differentapproachescanbeusedforcomparison
of cigarette smoke. According to ISO 4387 (International Or-
ganization for Standardization, 1991), analytes should be com-
pared on a per cigarette basis. However, there is an ongoing
debate as to whether other bases of comparison, such as equal
TPMorequalnicotine,mightbebettersuitedtoprovidealinkto
the human situation (e.g., WHO Study Group on Tobacco Reg-
ulation, 2004). We circumvent the limitations connected with a
comparison made on only one arbitrarily chosen basis by using
theEECRconcept(Terpstraetal.,2003).Thisapproachnotonly
utilizes principles well known from comparisons made on EC50
determinations, but allows for a relatively easy calculation of
EECRsforavarietyofotherbases.Table8providesanoverview
of the histopathological ﬁndings in the respiratory tract, a key
parameter of the toxicity study, calculated on a cigarette basis
(cigarette/m3), a TPM basis (µg TPM/L), and a nicotine basis
(µg nicotine/L). The comparisons on a cigarette basis reveal the
lowest EECRs for both EHC types, i.e., the lowest relative po-
tency compared to that of the conventional reference cigarette.
Insummary,theseinvivostudiesshowreducedtoxicological
activity of cigarette smoke by the addition of AMP to the pa-
per of an electrically heated cigarette in markers considered to
be linked to important risk factors for adverse health effects of
cigarettesmokingortoberiskfactorsthemselves,suchasCOfor
cardiovascular disease, clinical chemistry and organ weights for
systemic toxicity, histopathological ﬁndings in the nose for irri-
tation, and neutrophils in BALF for lung inﬂammation. Overall,
the EECRs indicate that the inhalation toxicity on a TPM basis
(i.e., per µg TPM/L) of MS from the EHC with AMP in the
cigarette paper is clearly lower than that of both the conven-
tional 1R4F and the EHC without AMP in the cigarette paper.
The same trend holds true on a nicotine basis and a cigarette
basis (Table 8).
Further studies are needed to clarify the relevance of these
potentially beneﬁcial effects of incorporating AMP into the
cigarette paper of the EHC to the human situation.
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